|
US8449908B2
(en)
|
2000-12-22 |
2013-05-28 |
Alltranz, Llc |
Transdermal delivery of cannabidiol
|
|
TWI369203B
(en)
|
2004-11-22 |
2012-08-01 |
Euro Celtique Sa |
Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
|
|
EP1827393A4
(en)
*
|
2004-12-09 |
2012-04-18 |
Insys Therapeutics Inc |
AT ROOM TEMPERATURE, STABLE DRONABINOL FORMULATIONS
|
|
KR100753959B1
(ko)
*
|
2006-01-12 |
2007-08-31 |
에이펫(주) |
기판 건조장치를 이용한 기판 건조방법
|
|
US20100184848A1
(en)
*
|
2006-07-14 |
2010-07-22 |
William Abraham Wine |
Transdermal formulations of synthetic cannabinoids and nano colloidal silica
|
|
US20080075768A1
(en)
*
|
2006-07-21 |
2008-03-27 |
Vaughn Jason M |
Hydrophobic opioid abuse deterrent delivery system using opioid antagonists
|
|
WO2008019146A2
(en)
*
|
2006-08-04 |
2008-02-14 |
Insys Therapeutics Inc. |
Aqueous dronabinol formulations
|
|
US8039509B2
(en)
|
2006-11-10 |
2011-10-18 |
Johnson Matthey Public Limited Company |
Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
|
|
US8980940B2
(en)
|
2006-11-10 |
2015-03-17 |
Johnson Matthey Public Limited Company |
Stable cannabinoid compositions and methods for making and storing them
|
|
DK2176208T3
(en)
*
|
2007-07-30 |
2015-04-27 |
Zynerba Pharmaceuticals Inc |
Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
|
|
JP2010535774A
(ja)
*
|
2007-08-06 |
2010-11-25 |
インシス セラピューティクス インコーポレイテッド |
経口カンナビノイド液体製剤および治療方法
|
|
US8222292B2
(en)
|
2007-08-06 |
2012-07-17 |
Insys Therapeutics, Inc. |
Liquid cannabinoid formulations
|
|
EP2534957B1
(en)
|
2007-12-14 |
2015-05-27 |
AeroDesigns, Inc |
Delivering aerosolizable products
|
|
GB0807915D0
(en)
*
|
2008-05-01 |
2008-06-04 |
Resolution Chemicals Ltd |
Production of delta 9 tetrahydrocannabinol
|
|
US8642080B2
(en)
*
|
2009-06-29 |
2014-02-04 |
Bender Analytical Holdong B.V. |
Drug delivery system comprising polyoxazoline and a bioactive agent
|
|
GB2471523A
(en)
|
2009-07-03 |
2011-01-05 |
Gw Pharma Ltd |
Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
|
|
TWI583374B
(zh)
|
2010-03-30 |
2017-05-21 |
Ｇｗ伐瑪有限公司 |
使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
|
|
EP2568965A1
(en)
|
2010-05-10 |
2013-03-20 |
Euro-Celtique S.A. |
Combination of active loaded granules with additional actives
|
|
US9700508B2
(en)
|
2010-05-10 |
2017-07-11 |
Euro-Celtique S.A. |
Pharmaceutical compositions comprising hydromorphone and naloxone
|
|
PH12012502083A1
(en)
|
2010-05-10 |
2017-07-26 |
Euro Celtique Sa |
Manufacturing of active-free granules and tablets comprising the same
|
|
US8703727B2
(en)
*
|
2010-08-24 |
2014-04-22 |
Aphios Corporation |
Nanotechnology formulation of poorly soluble compounds
|
|
US8629177B2
(en)
*
|
2010-08-24 |
2014-01-14 |
Aphios Corporation |
Nanoencapsulated delta-9-tetrahydrocannabinol
|
|
GB2487712B
(en)
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
EP2701534A1
(en)
|
2011-04-28 |
2014-03-05 |
ACME Specialty Products, LLC |
Taste masking compositions and edible forms thereof
|
|
US8758826B2
(en)
*
|
2011-07-05 |
2014-06-24 |
Wet Inc. |
Cannabinoid receptor binding agents, compositions, and methods
|
|
GB2514054A
(en)
|
2011-09-29 |
2014-11-12 |
Gw Pharma Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
US10350251B2
(en)
*
|
2012-03-28 |
2019-07-16 |
Keith Gerald Freeman |
Medical compositions, methods of making and using those compositions, and kits including those compositions
|
|
WO2013179264A2
(en)
*
|
2012-05-30 |
2013-12-05 |
Universidad Andres Bello |
Use of compounds that selectively modulate astrocytic release of substances through hemichannels of connexins and pannexins, without influencing gap junctions, for the treatment of psychiatric disorders
|
|
US12496271B2
(en)
|
2019-02-22 |
2025-12-16 |
Benuvia Operations, Llc |
Oral cannabinoid formulations
|
|
US11253472B2
(en)
|
2012-10-04 |
2022-02-22 |
Benuvia Therapeutics Llc |
Oral cannabinoid formulations
|
|
US9345771B2
(en)
|
2012-10-04 |
2016-05-24 |
Insys Development Company, Inc. |
Oral cannabinoid formulations
|
|
US10265293B2
(en)
|
2012-10-04 |
2019-04-23 |
Insys Development Company, Inc. |
Oral cannabinoid formulations
|
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
BR112015019180A8
(pt)
|
2013-02-12 |
2018-01-30 |
Corbus Pharmaceuticals Inc |
ácidos tetrahidrocanabinol-11-óicos ultrapuros
|
|
AU2013388034B2
(en)
|
2013-04-30 |
2019-08-15 |
Aspeya US Inc. |
Dry powder formulations and methods of use
|
|
US9616025B2
(en)
|
2013-10-29 |
2017-04-11 |
Echo Pharmaceuticals B.V. |
Compressed tablet containing Δ9-tetrahydrocannabinol, method for its manufacture and use of such tablet in oral treatment
|
|
CA2929321C
(en)
|
2013-10-29 |
2022-04-05 |
Echo Pharmaceuticals B.V. |
Compressed tablet containing cannabidiol, method for its manufacture and use of such tablet in oral treatment of psychosis or anxiety disorders
|
|
WO2015071380A1
(en)
|
2013-11-13 |
2015-05-21 |
Euro-Celtique S.A. |
Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
|
|
ES2791291T3
(es)
*
|
2014-01-13 |
2020-11-03 |
Kannalife Sciences Inc |
Nuevos 1,3-bencenodioles funcionalizados y su método de utilización para el tratamiento de la encefalopatía hepática
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
EP3160445B1
(en)
|
2014-06-26 |
2021-10-20 |
Island Breeze Systems Ca, LLC |
Mdi related products and methods of use
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
CN107075523B
(zh)
*
|
2014-06-27 |
2022-04-19 |
加拿大国家研究委员会 |
来自大麻的大麻环萜酚酸合酶
|
|
GB2531278A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
US20160143972A1
(en)
*
|
2014-11-21 |
2016-05-26 |
Cannamark Inc. |
Method and apparatus for preparing a solid form of cannabinoid
|
|
US10028919B2
(en)
|
2015-03-10 |
2018-07-24 |
Nanosphere Health Sciences, Llc |
Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms
|
|
GB2539472A
(en)
*
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
CA2999032A1
(en)
*
|
2015-09-24 |
2017-03-30 |
Pasenture, Inc. |
Cannabinoid compositions and methods of making
|
|
AU2017216928B2
(en)
*
|
2016-02-11 |
2018-09-20 |
Gelpell Ag |
Oral solid cannabinoid formulations, methods for producing and using thereof
|
|
US10542770B2
(en)
*
|
2016-03-18 |
2020-01-28 |
Aceso Wellness LLC |
Cannabinoid emulsion product and process for making the same
|
|
GB2548873B
(en)
|
2016-03-31 |
2020-12-02 |
Gw Res Ltd |
Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
|
|
BR112018071518A2
(pt)
|
2016-04-22 |
2019-02-19 |
Receptor Life Sciences, Inc. |
compostos medicinais à base de planta de ação rápida e suplementos nutricionais
|
|
EP4556457A3
(en)
*
|
2016-06-15 |
2025-06-18 |
Ojai Energetics PBC |
Methods and compositions for potentiating stem cell therapies
|
|
PT3474844T
(pt)
|
2016-06-28 |
2022-11-08 |
Trichomeshell Ltd |
Uma forma de dosagem para ser vaporizada e fumada
|
|
US9717683B1
(en)
|
2016-06-29 |
2017-08-01 |
Ep Pharma, Llc |
Low-temperature inhalation administration of cannabinoid entities
|
|
GB2551986A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Parenteral formulations
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
EA201892396A1
(ru)
*
|
2016-12-02 |
2019-04-30 |
Ресептор Лайф Сайенсиз, Инк. |
Быстродействующие растительные лекарственные соединения и биологически активные добавки
|
|
US10239808B1
(en)
|
2016-12-07 |
2019-03-26 |
Canopy Holdings, LLC |
Cannabis extracts
|
|
GB2557921A
(en)
|
2016-12-16 |
2018-07-04 |
Gw Res Ltd |
Use of cannabinoids in the treatment of angelman syndrome
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
US20190224117A1
(en)
*
|
2017-06-14 |
2019-07-25 |
Yury Leon Shmerlis |
Cannabis Extract Chewing Gum
|
|
GB2564383B
(en)
|
2017-06-23 |
2021-04-21 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
|
|
US11168047B2
(en)
|
2017-08-07 |
2021-11-09 |
Enantia, S.L. |
Cocrystal of 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-l,3-diol
|
|
AU2018323861B2
(en)
*
|
2017-08-27 |
2023-08-17 |
Rhodes Technologies |
Pharmaceutical compositions for the treatment of ophthalmic conditions
|
|
JP7493449B2
(ja)
|
2017-09-22 |
2024-05-31 |
ヴェクチュラ インコーポレイテッド |
ステアリン酸マグネシウムを含む乾燥粉末組成物
|
|
US10786456B2
(en)
|
2017-09-22 |
2020-09-29 |
Otitopic Inc. |
Inhaled aspirin and magnesium to treat inflammation
|
|
US10220061B1
(en)
|
2017-09-26 |
2019-03-05 |
Cynthia Denapoli |
Method of reducing stress and anxiety in equines
|
|
CA3300266A1
(en)
|
2017-09-28 |
2026-03-02 |
Harmony Biosciences Management, Inc. |
Treatment of fragile x syndrome with cannabidiol
|
|
US12582664B2
(en)
|
2017-09-28 |
2026-03-24 |
Harmony Biosciences Management, Inc. |
Treatment of fragile x syndrome with cannabidiol
|
|
GB2568929A
(en)
|
2017-12-01 |
2019-06-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US11179340B2
(en)
*
|
2017-12-29 |
2021-11-23 |
TGC Network LLC |
Cannabidiol dosage form
|
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
|
CA3089994A1
(en)
|
2018-01-31 |
2019-08-08 |
Canopy Holdings, LLC |
Hemp powder
|
|
GB201806953D0
(en)
|
2018-04-27 |
2018-06-13 |
Gw Res Ltd |
Cannabidiol Preparations
|
|
WO2020016656A2
(en)
*
|
2018-07-18 |
2020-01-23 |
Glatt Gmbh |
Extended release formulations of cannabinoids
|
|
EP3833369A4
(en)
|
2018-08-08 |
2022-05-04 |
Neptune Wellness Solutions Inc. |
PROCESS FOR COLD EXTRACTION OF CANNABINOIDS AND TERPENES FROM CANNABIS BY ORGANIC SOLVENTS
|
|
BR112021006858A2
(pt)
*
|
2018-10-10 |
2021-07-13 |
Tilray Inc. |
métodos e formulações para tratar náusea e vômito induzidos por quimioterapia
|
|
WO2020077153A1
(en)
|
2018-10-10 |
2020-04-16 |
Canopy Holdings, LLC |
Synthesis of cannabigerol
|
|
US11993563B2
(en)
|
2018-10-31 |
2024-05-28 |
Enantia S.L. |
Solid compositions of cocrystals of cannabinoids
|
|
EP3883595A4
(en)
|
2018-11-19 |
2022-12-14 |
Receptor Holdings, Inc. |
N-ACYLATED FATTY AMINO ACIDS TO REDUCE ABSORPTION VARIABILITY IN CANNABINOID-BASED COMPOSITIONS
|
|
CN117695226A
(zh)
|
2018-12-11 |
2024-03-15 |
迪斯拉普申实验室公司 |
用于递送治疗剂的组合物及其使用方法和制备方法
|
|
BR112021011509A2
(pt)
|
2018-12-14 |
2021-08-31 |
Natural Extraction Systems, LLC |
Composições e métodos relativos a moléculas de canabinoide aniônicas
|
|
US10609944B1
(en)
|
2018-12-14 |
2020-04-07 |
Natural Extraction Systems, LLC |
Compositions comprising 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate and 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
|
|
US10959961B2
(en)
|
2018-12-14 |
2021-03-30 |
Natural Extraction Systems, LLC |
Methods of administering anionic cannabinoid molecules dissolved in water
|
|
CA3122735A1
(en)
|
2018-12-14 |
2020-06-18 |
Zynerba Pharmaceuticals, Inc. |
Treatment of 22q11.2 deletion syndrome with cannabidiol
|
|
WO2020176526A1
(en)
*
|
2019-02-25 |
2020-09-03 |
Paul Mendell |
Methods for delivering nutritional and therapeutic supplements with food and drug products
|
|
CN112062697B
(zh)
*
|
2019-05-22 |
2023-09-01 |
上海特化医药科技有限公司 |
间苯多酚衍生物及其制备方法
|
|
CA3179235A1
(en)
*
|
2019-05-23 |
2020-11-26 |
Kare Chemical Technologies Inc. |
Catalytic cannabinoid processes and precursors
|
|
US20220233404A1
(en)
*
|
2019-06-26 |
2022-07-28 |
Natural Extraction Systems, LLC |
Containers, compositions, and methods related to cannabinoid anions
|
|
CA3151048A1
(en)
*
|
2019-09-18 |
2021-03-25 |
Robert O. Williams |
Compositions of cannabinoids for delivery by inhalation
|
|
US11542243B1
(en)
|
2019-09-26 |
2023-01-03 |
FusionFarms, LLC |
Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization
|
|
AU2020358869A1
(en)
|
2019-10-03 |
2022-04-14 |
Pike Therapeutics Usa, Inc. |
Transdermal delivery of dronabinol
|
|
US12409131B2
(en)
|
2019-10-03 |
2025-09-09 |
Pike Therapeutics Usa, Inc. |
Transdermal delivery of dronabinol
|
|
WO2021071967A1
(en)
*
|
2019-10-09 |
2021-04-15 |
Island Breeze Systems Ca, Llc |
Compositions for pulmonary delivery of cannabinoids and associated methods and systems
|
|
US20230339880A1
(en)
*
|
2019-10-11 |
2023-10-26 |
Corbus Pharmaceuticals, Inc. |
Compositions of ajulemic acid and uses thereof
|
|
EP4041209A4
(en)
|
2019-10-11 |
2024-01-24 |
Pike Therapeutics, Inc. |
TRANSDERMAL COMPOSITIONS COMPRISING CANNABIDIOL (CBD) FOR USE IN THE TREATMENT OF EPILEPTIC DISORDERS
|
|
US12016829B2
(en)
|
2019-10-11 |
2024-06-25 |
Pike Therapeutics Inc. |
Pharmaceutical composition and method for treating seizure disorders
|
|
CA3155181A1
(en)
|
2019-10-14 |
2021-04-22 |
Pike Therapeutics, Inc., 1219014 B.C. Ltd. |
Transdermal delivery of cannabidiol
|
|
US12268699B2
(en)
|
2019-10-14 |
2025-04-08 |
Pike Therapeutics Inc. |
Transdermal delivery of tetrahydrocannabinol
|
|
US12121617B2
(en)
|
2019-10-14 |
2024-10-22 |
Pike Therapeutics Inc. |
Transdermal delivery of cannabidiol
|
|
CA3158415A1
(en)
*
|
2019-10-21 |
2021-04-29 |
Esolate Ltd |
Compositions comprising superfine compounds and production thereof
|
|
GB2588455B
(en)
*
|
2019-10-25 |
2022-12-21 |
Gw Res Ltd |
Cannabinoid compound
|
|
GB2588456B
(en)
*
|
2019-10-25 |
2023-02-01 |
Gw Res Ltd |
Cannabinoid compound
|
|
GB2588457B
(en)
*
|
2019-10-25 |
2022-12-21 |
Gw Res Ltd |
Cannabinoid compound
|
|
US12391637B2
(en)
|
2019-11-11 |
2025-08-19 |
Natural Extraction Systems, LLC |
Methods to separate cannabinoids from impurities by crystallization
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
WO2021195540A1
(en)
*
|
2020-03-26 |
2021-09-30 |
Radient Technologies Innovations Inc. |
Cannabinoid based composition for mitigation of viral effects
|
|
CA3179442A1
(en)
|
2020-05-22 |
2021-11-25 |
Brian Warrington |
Compositions for treating acne and dermatological conditions
|
|
US12349706B2
(en)
|
2020-07-31 |
2025-07-08 |
Natural Extraction Systems, LLC |
Compositions and methods related to excipients and cannabinoid formulations
|
|
US11160757B1
(en)
|
2020-10-12 |
2021-11-02 |
GW Research Limited |
pH dependent release coated microparticle cannabinoid formulations
|
|
IL278286B
(en)
|
2020-10-25 |
2021-06-30 |
Fine Can Ltd |
Cannabis powders and their uses
|
|
US20240308943A1
(en)
*
|
2020-11-29 |
2024-09-19 |
Aphios Corporation |
Extraction, separation and purification of cannabinoids from cannabis staiva and other marijuana biomass
|
|
GB2602019A
(en)
|
2020-12-15 |
2022-06-22 |
Gw Res Ltd |
Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof
|
|
US20220317097A1
(en)
*
|
2021-04-05 |
2022-10-06 |
Grant Kraus |
Atmospheric Triphasic Chromatography (ATC) method
|
|
CA3217137A1
(en)
|
2021-04-29 |
2022-11-03 |
Christopher Adair |
Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof
|
|
US20220387256A1
(en)
*
|
2021-06-03 |
2022-12-08 |
Kent Byron |
Vial With Metered Dispenser
|
|
WO2023015102A1
(en)
*
|
2021-07-26 |
2023-02-09 |
Rapid Therapeutic Sciences Laboratories, Inc. |
Process for producing cbd isolate
|
|
PL4124336T3
(pl)
|
2021-07-30 |
2024-02-26 |
Cannamedical Pharma Gmbh |
Plaster przezśluzówkowy obejmujący kannabinoid i/lub opioid
|
|
AU2023321655A1
(en)
|
2022-08-12 |
2025-02-13 |
Jazz Pharmaceuticals Research Uk Limited |
Oral solid dosage forms comprising cannabinoids
|
|
CN115784836A
(zh)
*
|
2022-12-08 |
2023-03-14 |
南京康立瑞生物科技有限公司 |
一种高选择性的制备反式-薄荷基-2,8-二烯-1-醇的方法
|
|
WO2024160792A1
(en)
|
2023-01-30 |
2024-08-08 |
Cannamedical Pharma Gmbh |
Improved transmucosal patch comprising a cannabinoid and/or an opioid
|
|
KR102952971B1
(ko)
*
|
2023-06-01 |
2026-04-15 |
충남대학교 산학협력단 |
올리베톨 또는 이의 약제학적으로 허용가능한 염을 유효성분으로 포함하는, 뇌전증 또는 퇴행성 신경질환의 예방 및 치료용 약학 조성물
|
|
WO2025164161A1
(ja)
*
|
2024-01-29 |
2025-08-07 |
シオノギファーマ株式会社 |
カンナビジオールの溶媒和物及びカンナビジオールの精製方法
|
|
US12605394B2
(en)
|
2024-07-25 |
2026-04-21 |
Visionary Assets, Llc |
Compositions containing cannabinoid nanoparticles
|